Insights from ELZA’s contributions to the World Keratoconus Congress 2026 in Florence – ELZA PACE, CXL innovation, and personalised keratoconus treatment strategies
Can sunlight and riboflavin (vitamin B2) treat keratoconus? New publication explains why current evidence does not support it.
At the 10th SAoO Congress in Lucerne, Dr. Emilio Torres-Netto examined how advances in keratoconus care may further reduce the need for keratoplasty by 2040
A January 2026 The Ophthalmologist article outlines how personalised CXL is applied in three real-world scenarios: good vision, cataract planning, and markedly irregular corneas.
Emilio Torres-Netto reviewed the evolution of epi-on CXL at KCXL 2025, explaining early failures and how modern protocols now achieve clinically meaningful keratoconus stabilisation.
ELZA joined the SCHWIND User Meeting 2025 in Bangkok to share our insights on advanced laser eye surgery.
Cataract surgery in keratoconus requires individualized biometry, conservative IOL choice, and careful corneal planning.
ELZA Institute’s Dr. Torres-Netto presents advances in surgical keratoconus treatment and ELZA-PACE-CXL at AAO 2025.
Auf dem ESCRS 2025 in Kopenhagen präsentierte Dr. Emilio A. Torres-Netto neue Strategien zur Behandlung von Patienten mit Katarakt und Keratokonus – einer besonders anspruchsvollen Kombination.
The ELZA team presented at OPT-X.25 in Baden, showcasing our Zurich keratoconus treatment expertise from diagnostics and contact lenses to advanced surgical care
